Mass Spectrometry-Based Assessment of M-Protein in Peripheral Blood during Maintenance Therapy in Multiple Myeloma (MM) in the Phase III ATLAS Trial

Authors
Category Primary study
JournalBLOOD
Year 2023
This article has no abstract
Epistemonikos ID: bbecc29aa1a975a45ce6a07141661fefc93d963b
First added on: Apr 29, 2024